01 1ScinoPharm Taiwan Ltd.
01 1Ganaxolone
01 1Taiwan
NDC Package Code : 65129-3162
Start Marketing Date : 2021-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
53
PharmaCompass offers a list of Ganaxolone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ganaxolone manufacturer or Ganaxolone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ganaxolone manufacturer or Ganaxolone supplier.
PharmaCompass also assists you with knowing the Ganaxolone API Price utilized in the formulation of products. Ganaxolone API Price is not always fixed or binding as the Ganaxolone Price is obtained through a variety of data sources. The Ganaxolone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ganaxolone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ganaxolone, including repackagers and relabelers. The FDA regulates Ganaxolone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ganaxolone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ganaxolone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ganaxolone supplier is an individual or a company that provides Ganaxolone active pharmaceutical ingredient (API) or Ganaxolone finished formulations upon request. The Ganaxolone suppliers may include Ganaxolone API manufacturers, exporters, distributors and traders.
click here to find a list of Ganaxolone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ganaxolone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ganaxolone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ganaxolone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ganaxolone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ganaxolone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ganaxolone suppliers with NDC on PharmaCompass.
We have 1 companies offering Ganaxolone
Get in contact with the supplier of your choice:
